The increase suggests that disruptions in important healthcare screenings due to the pandemic are tapering off, according to Bloomberg.
As procedures like early-detection cancer screenings declined in 2020, Mr. Cordani said the payer focused on getting patients back to their providers.
“It’s a very good thing and something that our team has worked tirelessly to try to effectuate, elevating those levels,” Mr. Cordani said in a call with analysts May 7.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
